Idorsia Ltd. (IDRSF)
5.75
0.00 (0.00%)
USD |
OTCM |
Jun 08, 16:00
Idorsia Research and Development Expense (Quarterly) : 33.91M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| BeOne Medicines Ltd. | 521.31M |
| AC Immune SA | 14.99M |
| CRISPR Therapeutics AG | 66.37M |
| ADC Therapeutics SA | 19.88M |
| MoonLake Immunotherapeutics | 53.67M |